human | Q5 |
P108 | employer | University of California, Irvine | Q868421 |
P735 | given name | Hoda | Q93997185 |
Hoda | Q93997185 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q36028422 | "You're too young for this": adolescent and young adults' perspectives on cancer survivorship |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q50050039 | 36-Item Short Form Survey (SF-36) Versus Gait Speed As Predictor of Preclinical Mobility Disability in Older Women: The Women's Health Initiative. |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q59355837 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk |
Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
Q29417084 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. |
Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
Q41431475 | A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q42751909 | A pilot study of male breast cancer in the Veterans Affairs healthcare system |
Q34392696 | A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia |
Q36946511 | A targeted genetic association study of epithelial ovarian cancer susceptibility |
Q33637973 | A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important |
Q27908547 | A validation method to determine missing years of birth in a cohort study of shipyard workers using social security number |
Q36671218 | ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer |
Q61948755 | Abstract 3266: Expression quantitative trait locus analysis of triple negative breast cancer |
Q37212841 | Abstracting height and weight from medical records, and breast cancer pathologic factors |
Q44498341 | Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). |
Q34039577 | Activating mutation in MET oncogene in familial colorectal cancer |
Q46193621 | Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study |
Q33619769 | Adenomyosis and endometriosis in the California Teachers Study |
Q34501012 | Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis |
Q43663669 | Adherence to treatment guidelines for ovarian cancer as a measure of quality care |
Q38406780 | Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study |
Q52647897 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. |
Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
Q30779634 | Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases |
Q34386913 | Ambient UV, personal sun exposure and risk of multiple primary melanomas |
Q31036541 | Analysis of co-aggregation of cancer based on registry data |
Q36831854 | Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome |
Q46851695 | Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates |
Q37584843 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q30276986 | Assessing the genetic architecture of epithelial ovarian cancer histological subtypes |
Q30277151 | Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors |
Q37684409 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer |
Q35801085 | Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
Q33864503 | Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies |
Q24619808 | Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies |
Q46006754 | Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults. |
Q37200998 | Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q38659977 | Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma |
Q37103054 | Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways |
Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q33733255 | Association of single nucleotide polymorphisms of nicotinic acetylcholine receptor subunits with cervical neoplasia |
Q39423088 | Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study |
Q40069925 | Associations of MC1R genotype and patient phenotypes with BRAF and NRAS mutations in melanoma |
Q37403674 | Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q34293070 | Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q63628486 | Associations of sleep duration with cardiometabolic outcomes in American Indians and Alaska Natives and other race/ethnicities: results from the BRFSS |
Q37640500 | Attitudes Toward Cancer Clinical Trial Participation in Young Adults with a History of Cancer and a Healthy College Student Sample: A Preliminary Investigation |
Q46002468 | Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. |
Q24531993 | Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies |
Q57306053 | BRAF polymorphisms and the risk of ovarian cancer of low malignant potential |
Q44312982 | BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype |
Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
Q36004066 | Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort |
Q22250878 | Body-Mass Index and Mortality among 1.46 Million White Adults |
Q43073201 | Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies |
Q39642676 | Breast cancer risk and methylenetetrahydrofolate reductase polymorphism |
Q59806739 | Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study |
Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
Q46138590 | Breast cancer survival and hormone replacement therapy: a cohort analysis |
Q41728829 | Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype |
Q41747817 | Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q50915196 | Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program. |
Q43765024 | Cancer incidence rates in Turkey in 2006: a detailed registry based estimation |
Q33833595 | Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer |
Q38627972 | Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013. |
Q46164918 | Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival |
Q40617146 | Characteristics and survival of patients with non-Hodgkin's lymphoma with and without acquired immunodeficiency syndrome |
Q41745402 | Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer |
Q46778926 | Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases |
Q35782435 | Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer |
Q46525423 | Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use? |
Q36009587 | Clinically relevant changes in family history of cancer over time |
Q37657957 | Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer |
Q35668946 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk |
Q34082534 | Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis |
Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q36255665 | Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q40718941 | Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations |
Q46054916 | Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study |
Q30366026 | Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q34342248 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q45072330 | Correlates of active and passive smoking in the California Teachers Study cohort |
Q30745400 | Correlates of vitamin supplement use in the United States: data from the California Teachers Study cohort |
Q44775873 | Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity |
Q46901727 | Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California |
Q70987172 | Detection of BRCA1 mutations by the protein truncation test |
Q45236816 | Diet and melanoma in a case-control study |
Q55115973 | Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer. |
Q36168230 | Diet and risk of ovarian cancer in the California Teachers Study cohort |
Q46082238 | Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer |
Q46060448 | Differences in breast cancer stage at diagnosis between non-Hispanic white and Hispanic populations, San Diego County 1988-1993. |
Q46349072 | Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease |
Q37196974 | Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study |
Q36104999 | Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States |
Q46036652 | Dynamical interactions between multiple cancers. |
Q33824208 | ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study |
Q24810775 | Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer |
Q46833375 | Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study |
Q41868438 | Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility. |
Q28282443 | Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors |
Q53591906 | Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. |
Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
Q36487146 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk |
Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q57306046 | Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium |
Q34315534 | Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk |
Q36966218 | Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study |
Q35897406 | Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population |
Q21144976 | Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot" |
Q37690220 | Evaluation of ultra-deep targeted sequencing for personalized breast cancer care |
Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q38845261 | Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk |
Q37135256 | Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study |
Q46629818 | Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial |
Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
Q46214201 | Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
Q46737142 | Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening. |
Q39565188 | Gene-environment interactions in renal cell carcinoma |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q62583135 | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34453723 | Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q40060942 | Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study |
Q36218993 | Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q33778612 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. |
Q35904590 | Genome-wide significant risk associations for mucinous ovarian carcinoma |
Q33410700 | Genotype determination for polymorphisms in linkage disequilibrium |
Q28146076 | Germ-line msh6 mutations in colorectal cancer families |
Q21195235 | Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q40631500 | High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). |
Q45236849 | High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease |
Q46547993 | Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma |
Q40060927 | History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium |
Q46446899 | Hormone replacement therapy in breast cancer survivors: a cohort study |
Q31094109 | How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma? |
Q41115943 | Human Nail Clippings as a Source of DNA for Genetic Studies |
Q41127637 | Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer |
Q34134850 | Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort |
Q46950052 | Hypertension, diuretics and breast cancer risk |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q41460285 | Immune response in shipyard workers with x ray abnormalities consistent with asbestos exposure |
Q34470171 | Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival |
Q41757407 | Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California |
Q45025588 | Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy |
Q46394081 | Incidence of lung cancer by histological type from a population-based registry |
Q45970323 | Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. |
Q35674870 | Inherited genetic variants associated with occurrence of multiple primary melanoma |
Q37684424 | Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q35181234 | Inherited variation at MC1R and ASIP and association with melanoma-specific survival |
Q35581399 | Inherited variation at MC1R and histological characteristics of primary melanoma |
Q46301216 | Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995. |
Q42965794 | Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population |
Q30277784 | Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer |
Q33807955 | Kids, adolescents, and young adult cancer study-a methodologic approach in cancer epidemiology research |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q37725393 | Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q37353491 | Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors |
Q34561891 | Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample |
Q46219463 | Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study |
Q46196878 | Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis |
Q46592067 | Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q43793910 | Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status |
Q24618839 | Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X |
Q37705148 | MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors |
Q45094724 | Malignancies following in situ cervical cancer in Hispanic Americans and non-Hispanic Whites |
Q34097339 | Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study |
Q36450416 | Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q33872685 | Misclassification of bronchioloalveolar carcinoma with cytologic diagnosis of lung cancer. |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q36015876 | Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q35238410 | Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. |
Q46506976 | Natural history of stage I non-small cell lung cancer: implications for early detection |
Q46659535 | Negative Valence Life Events Promote Breast Cancer Development |
Q26799669 | Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk |
Q39832874 | Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma |
Q36736270 | New perspectives on melanoma pathogenesis and chemoprevention. |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q30275832 | No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival |
Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
Q28176257 | Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status |
Q34432899 | Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis |
Q35892049 | Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study |
Q37378287 | Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium |
Q36027025 | Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium |
Q41821809 | Occupation and bladder cancer risk |
Q46419885 | Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group |
Q46701873 | Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
Q44790500 | Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort |
Q46147249 | Physical activity and colon cancer risk among women in the California Teachers Study |
Q40798938 | Pilot study of blood biomarker candidates for detection of pancreatic cancer |
Q45073049 | Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q33891803 | Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium |
Q24648412 | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q34562188 | Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study |
Q33921008 | Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium |
Q44634512 | Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma |
Q30432372 | Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q44954543 | Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS. |
Q43638007 | Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). |
Q46634553 | Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. |
Q37205563 | Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry |
Q45985654 | Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. |
Q35223068 | Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer |
Q34958895 | Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q46502344 | Quality of life in long-term cervical cancer survivors |
Q33629332 | Quality of life, characteristics and survival of patients with HIV and lymphoma |
Q36009422 | RAD51B in Familial Breast Cancer |
Q46016968 | Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. |
Q46263558 | Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States |
Q52759419 | Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. |
Q53698034 | Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. |
Q37223616 | Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations |
Q46351229 | Recruitment strategies for cervical cancer prevention study |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q46060490 | Regional variations in breast cancer among california teachers |
Q36567726 | Relation between self-recalled childhood physical activity and adult physical activity: The women's health initiative |
Q37268628 | Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS |
Q46348083 | Reproductive history and risk of second primary breast cancer: the WECARE study |
Q39705133 | Residential mobility in the California Teachers Study: implications for geographic differences in disease rates |
Q46338113 | Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort |
Q39326953 | Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci |
Q46019480 | Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. |
Q46213825 | Risk factors for acute myeloid leukemia and multiple myeloma: a combination of GIS and case-control studies. |
Q45989361 | Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population-based case series. |
Q33946233 | Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q36047747 | Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers |
Q37624504 | Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 |
Q46480759 | Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups |
Q35749402 | Risk of second primary cancer in men with breast cancer |
Q38716934 | Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence |
Q33310470 | Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis |
Q28392744 | Self-recalled Youth Physical Activity and Postmenopausal Cardiovascular Disease |
Q44781581 | Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women |
Q41714936 | Sense of control and adjustment to breast cancer: the importance of balancing control coping styles |
Q39673090 | Sex Differences in the Relationship between Fitness and Obesity on Risk for Asthma in Adolescents |
Q45975068 | Sex differences in lung-cancer risk associated with cigarette smoking. |
Q38835179 | Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure |
Q36089391 | Shared genetics underlying epidemiological association between endometriosis and ovarian cancer |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q64004349 | Shared heritability and functional enrichment across six solid cancers |
Q41695180 | Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. |
Q37151786 | Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer |
Q46366642 | Single-visit program for cervical cancer prevention in a high-risk population |
Q37515856 | Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines |
Q34002907 | Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma |
Q37486453 | Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer |
Q30583547 | Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status |
Q24794680 | Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study |
Q34287821 | Sun exposure and melanoma survival: a GEM study |
Q28601736 | Supplementing Public Health Inspection via Social Media |
Q37337219 | Survival after colorectal cancer diagnosis is associated with colorectal cancer family history |
Q46034086 | Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. |
Q37273985 | Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study |
Q46134121 | Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules |
Q40017336 | TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases |
Q38901654 | Temporal Evaluation of Polybrominated Diphenyl Ether (PBDE) Serum Levels in Middle-Aged and Older California Women, 2011-2015. |
Q46737483 | Testing targeted approaches to enhance Cancer Genetics Network minority recruitment within Asian populations |
Q46033349 | The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care. |
Q36615665 | The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q24806109 | The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer |
Q38461745 | The Cancer Genetics Network: recruitment results and pilot studies |
Q35268940 | The association between circulating total folate and folate vitamers with overall survival after postmenopausal breast cancer diagnosis |
Q50709318 | The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. |
Q35636609 | The association of body mass index with mortality in the California Teachers Study |
Q35558999 | The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort |
Q36836192 | The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial |
Q48224142 | The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival |
Q44659348 | The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study |
Q41889897 | The relationship of blood- and urine-boron to boron exposure in borax-workers and usefulness of urine-boron as an exposure marker |
Q39479396 | The risk of invasive cervical cancer among Hispanics: evidence for targeted preventive interventions |
Q35024008 | The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q43567726 | The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. |
Q46903376 | Time Trends in Per- and Polyfluoroalkyl Substances (PFASs) in California Women: Declining Serum Levels, 2011-2015. |
Q40782001 | Treatment for T1a Renal Cancer Substratified by Size: "Less is More". |
Q46080721 | Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ |
Q37289626 | Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study |
Q36977055 | Type I and II endometrial cancers: have they different risk factors? |
Q46102092 | Unique features of gastric carcinoma in the young: a population-based analysis |
Q30883850 | Validating California Teachers Study Self-Reports of Recent Hospitalization: Comparison with California Hospital Discharge Data |
Q37081074 | Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium |
Q30766723 | Validation of family history data in cancer family registries |
Q46459235 | Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry |
Q31140446 | Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry |
Q36711004 | Validity of models for predicting BRCA1 and BRCA2 mutations |
Q37430032 | Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study |
Q56342454 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility |
Q30438940 | Variants in the ATM gene associated with a reduced risk of contralateral breast cancer |
Q33847791 | Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer |
Q24646346 | Variation of breast cancer risk among BRCA1/2 carriers |
Q36468811 | Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study |
Q35103696 | Vitamin D receptor polymorphisms in patients with cutaneous melanoma |
Q35575288 | Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort |
Q41672358 | Young age as a prognostic factor in cervical cancer: results of a population-based study |
Q56334023 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology |
Search more.